wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422543-615DFD45-7064-40FA-8E99-DFB17842F763
Q33422543-615DFD45-7064-40FA-8E99-DFB17842F763
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-615DFD45-7064-40FA-8E99-DFB17842F763
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies
P304
Q33422543-615DFD45-7064-40FA-8E99-DFB17842F763
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-615DFD45-7064-40FA-8E99-DFB17842F763
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d7ab975b2c3f71d26db42360790970f5805f52cc
P304
669-678
http://www.w3.org/2001/XMLSchema#string